Replek Overview
- Founded
- 1945

- Status
- Public
- Employees
- 408

- Stock Symbol
- REPL

- Share Price
- $2.08K
- (As of Tuesday Closing)
Replek General Information
Description
Replek AD is engaged in the development, design and production of generic medicines. The company develops drugs in different pharmaceutical therapeutic categories including anti-platelet, lipid-lowering, atypical antipsychotic, anti-infective, among others. It manufactures drugs in different forms including tablets, capsules, oral solutions, creams and ointments. Its product portfolio consists of Clopidogrel, Atorvastatin, Simvastatin, risperidone, Clarythromycin, Ciprofloxacin, Meloksikam, Risperidon, terazosin, among others. Replek also offers cannabis oil products, food supplements and cosmetics.
Contact Information
- Kozle st. 188
- Skopje, 1000
- Macedonia
Replek Stock Performance
(As of Tuesday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$2.08K | $2.05K | $1.41K - $2.12K | 4.27 |
Replek Financials Summary
In Thousands, USD |
TTM 30-Sep-2018 | FY 2017 31-Dec-2017 | FY 2016 31-Dec-2016 | FY 2015 31-Dec-2015 |
---|---|---|---|---|
EV | 32,317 | 26,858 | 19,416 | 18,679 |
Revenue | 19,490 | 17,364 | 14,768 | 14,500 |
EBITDA | 2,865 | 2,691 | 2,222 | 1,900 |
Net Income | 2,465 | 2,348 | 1,939 | 1,649 |
Total Assets | 34,809 | 29,954 | 30,332 | |
Total Debt | 0 | 1,218 | 1,567 | 1,174 |
Replek Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trial